peptidoleukotrienes

peptidoleukotrienes are potent bronchoconstrictors involved in the pathogenesis of asthma.

antagonists of peptidoleukotrienes are effective in treating allergic rhinitis symptoms.

researchers measured the release of peptidoleukotrienes during the hypersensitivity reaction.

cysteinyl peptidoleukotrienes cause edema by increasing vascular permeability in tissues.

montelukast functions by blocking specific peptidoleukotriene receptors in the airways.

biosynthesis of peptidoleukotrienes depends on the 5-lipoxygenase enzyme pathway.

high levels of peptidoleukotrienes were detected in the patients' urine samples.

inhibiting peptidoleukotriene production can significantly reduce airway inflammation.

the biological activity of peptidoleukotrienes was studied using isolated cells.

peptidoleukotrienes play a critical role in anaphylactic shock and hypotension.

doctors prescribe peptidoleukotriene receptor antagonists for chronic asthma management.